Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Ibsa Institut Biochimique SA has 1 pending office action currently under review. This activity involves 1 distinct examiner, indicating a very focused scope of current prosecution at the USPTO.
KIM, SEONG JONG is the busiest examiner for the company. This examiner is managing 1 pending office action. With only 1 distinct examiner identified in the data, the outcome of the company's current pending matter depends entirely on the specific feedback and requirements of this single official.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18944936 | High-Stability Packaged Solutions of T4 Thyroid Hormone | KIM, SEONG JONG | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18944936 | High-Stability Packaged Solutions of T4 Thyroid Hormone | KIM, SEONG JONG | — | §103Other | Non-Final OA | — | Pending | Nov 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial